Fix up look sharp CRISPR, the NIH is watching. Gene-editing technique set for RCA appearance to review potential first-in-man application
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
A new study suggests that the downward trend in clinical trial success may be reversing, up from 7.5 percent in 2011 to 11 percent over the past two years
Using genome sequencing researchers from the University of British Columbia have worked out how to tell when a tuberculosis outbreak is over
Thermo Fisher Scientific and West China Hospital Partner on Joint Research Platform for Precision Medicine
Thermo Fisher Scientific announce partnership with West China Hospital of Sichuan University to develop a joint platform to research precision medicine
Landmark study shows genetic changes explain differences in survival for young AML patients
A pair of mobile DNA sequencing laboratories are travelling through areas worst-hit by Zika virus
Part of the National Cancer Moonshot, GDC to centralise, standardise accessible data.
Wendy Rubinstein looks at why getting genomics to physicians’ desks is proving so problematic
Testing for metabolic changes in the blood could indicate whether a cancer drug is working as designed, a new study reports
A genetic mutation that confers a 70 percent chance of developing multiple sclerosis could point the way for new therapies